Human breast cancer cells (HCC1806-EGFP)

The HCC1806-EGFP human breast cancer cells offer significant applications in cancer research and biomedical studies providing insights into tumor biology and the efficacy of new treatment strategies These cells characterized by their epithelioid nature and adherence properties allow researchers to investigate the underlying mechanisms of breast cancer progression and response to therapy when cultured in a 90% RPMI-1640 and 10% FBS medium

When preserved in dry ice for transportation HCC1806-EGFP cells ensure optimal viability for in vitro studies facilitating experiments that explore the effects of various pharmacological agents and gene therapies on cancer cell behavior Additionally their negative viral status and stable transfection contribute to the robustness of findings enabling researchers to advance the development of targeted therapies and personalized medicine approaches in oncology

Overall the adaptability and reliability of HCC1806-EGFP cells as a model system enhance the understanding of breast cancer contributing to innovative solutions in treatment and care